Health Biotchnology Portfolio Fund Technical Analysis

SHPCX Fund  USD 14.14  -0.05  -0.35%   
As of the 18th of March 2026, the last recorded price for Health Biotchnology is 14.14 per share. Primary technical drivers reflect risk adjusted performance of 0.0529, and Market Risk Adjusted Performance of 0.1041. Quantitative analysis incorporates volatility metrics and price behavior to assess directional bias. Metrics are compared to industry averages to assess relative positioning.

Health Biotchnology Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Health, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Health
  
Health Biotchnology's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
The concept of value for Health Biotchnology differs from its quoted price, since each reflects a different lens. For Health Biotchnology, key inputs include a P/E ratio of 18.07, and a P/B ratio of 2.64. Health Biotchnology's market quotation reflects the latest level where a willing buyer met a willing seller.

What if' Analysis

What-if analysis for Health Biotchnology Portfolio is essentially a historical sensitivity test that shows how changes in the investment horizon could have altered realized return, drawdown, and timing outcomes. Valuation should still be reviewed through market value, enterprise value, revenue scale, and balance-sheet quality. The point is not to predict the future from one chart, but to understand how sensitive the trade has been to timing and holding assumptions.
0.00
12/18/2025
 
No Change 0.00  0.0 
In 3 months and 1 day
 
03/18/2026
0.00
An initial  0.00  allocation to Health Biotchnology on December 18, 2025 held through today would generate 0.00 in total gains. This reflects a 0.0% cumulative return in Health Biotchnology in aggregate across 90 days. Health Biotchnology is related to or competes with FEDERATED HIGH, Blrc Sgy, NUVEEN HIGH, MASSMUTUAL PREMIER, MEDIUM DURATION, WESTCORE PLUS, and BUFFALO HIGH. The list provides context for relative analysis. The fund will normally invest at least 80 percent of its total assets in equity securities of U.S More

Momentum Range Indicators for Health Biotchnology Signals

These indicators describe how Health Biotchnology momentum evolves across recent price ranges. The indicators are presented as neutral context for price dynamics.

Volatility and Risk Indicators for Health Biotchnology Overview

These indicators track Health Biotchnology's volatility and return range dynamics. The measures summarize variability without implying direction.
The concept of mean reversion suggests that Health Biotchnology's price will eventually return toward its long-run average. High prices may deter value investors, while unusually low prices often attract buyers who anticipate a recovery.
Hype
Prediction
LowEstimatedHigh
13.0513.9614.87
Details
Intrinsic
Valuation
LowRealHigh
13.3214.2315.14
Details
Naive
Forecast
LowNextHigh
13.0213.9414.85
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
14.0414.4414.83
Details
Competitive analysis for Health Biotchnology compares its financial performance, valuation multiples, and growth trajectory against sector peers. This peer-relative view often uncovers mispricing that single-company analysis would miss.

Technical Indicators

Health Biotchnology Backtested Returns

Over the selected 3 months, Health Biotchnology demonstrates a very low volatility profile. It exhibits a Sharpe Ratio (Efficiency) of 0.0462, highlighting adjusted efficiency metrics. We identified twenty-seven technical indicators influencing the company's volatility profile. Please analyze metrics such as risk-adjusted performance of 0.0529, and market risk-adjusted performance of 0.1041 to assess dispersion and downside exposure. The fund owns a Beta (Systematic Risk) of 0.52, which conveys possible diversification benefits within a given portfolio. With a sub-1 beta, Health Biotchnology participates in market rallies at a reduced pace while also limiting downside exposure.
Auto-correlation
    
  0.15  

Insignificant predictability

Health Biotchnology Portfolio exhibits insignificant predictability. Autocorrelation measures the degree of predictability between Health Biotchnology time series from 18th of December 2025 to 1st of February 2026 and from 1st of February 2026 to 18th of March 2026. Persistent correlation between intervals suggests underlying momentum patterns in Health Biotchnology that may carry forward. The measured coefficient of 0.15 means less than 15.0% of Health Biotchnology's recent price variance traces back to prior period behavior.
Correlation Coefficient0.15
Spearman Rank Test-0.24
Residual Average0.0
Price Variance0.04
Technical analysis for Health Biotchnology evaluates price and volume patterns over time. Common inputs include moving averages, RSI, regressions, and price-return correlations.
This view emphasizes price behavior and trend signals over external narrative drivers. This framework highlights recurring patterns and trend context. More Info...

Technical Analysis

Indicator
Time Period
Execute Indicator
This analysis covers thirty-seven data points across the selected time horizon. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Health Biotchnology volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Technical Analysis Methodology & Indicators

Technical analysis of Health Biotchnology focuses on NAV trend behavior and volatility patterns where pricing frequency permits. Volume and liquidity conditions influence signal reliability. Reduced trading volume may increase short-term pricing variability.

For Health Biotchnology Portfolio, this section uses fund disclosures and market reference feeds with Macroaxis normalization rules applied to keep cross-asset comparisons consistent. Intraday timing differences may exist.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on February 24th, 2026

Health Biotchnology Technical Indicators

Technical indicators tied to Health Biotchnology Portfolio help investors translate chart behavior into a more structured framework for entry, exit, and risk control. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.

March 18, 2026 Daily Trend Indicators

Technical indicators tied to Health Biotchnology Portfolio help investors translate chart behavior into a more structured framework for entry, exit, and risk control. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.